College of Life Science and Technology, Third Affiliated Hospital, Xinxiang Medical University, Xinxiang, China; Key Laboratory of Medical Protective Equipment in Henan Province, Henan Yadu Industrial Co., Ltd, Xinxiang, China.
College of Pharmacy, Xinxiang Medical University, Xinxiang, China.
Int J Biol Macromol. 2024 Aug;274(Pt 1):133278. doi: 10.1016/j.ijbiomac.2024.133278. Epub 2024 Jun 19.
Removing free hemoglobin generated during extracorporeal circulation remains a challenge. Currently, there is no adsorbent with specificity and good biosafety for removing hemoglobin. In this study, a new chitosan/sodium alginate/carbon nitride (CS/SA/CN) hydrogel adsorbent was prepared by blending SA with CN to drop into CS/CaCl solution. The physicochemical properties of CS/SA/CN hydrogel were evaluated using some techniques, including scanning electron microscope, Zeta potential measurement, and thermogravimetric analysis. Hemoglobin adsorption in vitro, stability, hemocompatibility, cell compatibility, inflammatory reaction and blood extracorporeal circulation in vivo were also evaluated. The findings revealed that the CS/SA/CN-0.4 % hydrogel exhibited an impressive adsorption capacity of 142.35 mg/g for hemoglobin. The kinetic data of hemoglobin adsorption were well-described by pseudo second-order model, while the isothermal model data conformed to the Langmuir model. The hardness and modulus of CS/SA/CN-0.4 % was 11.7 KPa and 94.66 KPa respectively, which indicated robust resistance to breakage. CS/SA/CN demonstrated excellent hemocompatibility, biocompatibility and anti-inflammatory properties. In addition, the results of in vivo rabbit extracorporeal blood circulation experiment demonstrated that CS/SA/CN could adsorb free hemoglobin from blood while maintaining high biosafety standard. Consequently, CS/SA/CN hydrogel emerges as a promising candidate for use as a hemoglobin adsorbent in extracorporeal blood circulation system.
去除体外循环过程中产生的游离血红蛋白仍然是一个挑战。目前,还没有一种具有特异性和良好生物安全性的吸附剂用于去除血红蛋白。在这项研究中,通过将 SA 与 CN 混合并滴入 CS/CaCl 溶液中,制备了一种新型壳聚糖/海藻酸钠/氮化碳(CS/SA/CN)水凝胶吸附剂。使用扫描电子显微镜、Zeta 电位测量和热重分析等技术评估了 CS/SA/CN 水凝胶的物理化学性质。还评估了体外血红蛋白吸附、稳定性、血液相容性、细胞相容性、炎症反应和体内血液体外循环。结果表明,CS/SA/CN-0.4%水凝胶对血红蛋白具有令人印象深刻的 142.35mg/g 的吸附能力。血红蛋白吸附的动力学数据很好地描述了伪二阶模型,而等温模型数据符合朗缪尔模型。CS/SA/CN-0.4%的硬度和模量分别为 11.7kPa 和 94.66kPa,表明其具有很强的抗断裂能力。CS/SA/CN 表现出优异的血液相容性、生物相容性和抗炎性能。此外,兔体外血液循环实验结果表明,CS/SA/CN 可以从血液中吸附游离血红蛋白,同时保持高生物安全性标准。因此,CS/SA/CN 水凝胶作为体外血液循环系统中血红蛋白吸附剂具有广阔的应用前景。